Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Baxter Expands Lyo-Capacity | Contract Pharma

What are you searching for?

Sign in
Breaking News

Baxter Expands Lyo-Capacity

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Baxter Healthcare Corp. has expanded lyophilization capacity at its Halle, Germany facility to support the growth of its Baxter BioPharma Solutions (BPS) cytotoxic contract manufacturing business. Two large-scale lyophilization chambers will be added to freeze-dry cancer therapies for its pharma and biopharma partners. The expansion will be complete and fully validated by mid-2007.

“We are expanding to meet the growing demands of the cytotoxic manufacturing market,” said Tom Polen, senior director of marketing for BPS. “As a leader in the industry, we look forward to providing greater capacity and continuing to advance our track record for delivering safe, high-quality products for our customers.”

The lyophilization chambers, which will include technologies such as handling of organic solvents, will be designed to optimize product quality and safety to ensure product integrity. An automated vial loading system and new in-process quality analysis technology will provide advanced control over the manufacturing process to help ensure the highest quality product is produced.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics